Gilead withdraws their Orphan Drug Status application for hope COVID-19 treatment, Remdesivir.
As we reported earlier this week the US Food & Drug Administration (FDA) granted Gilead Sciences' application to grant their antiviral treatment, Remdesivir, Orphan Drug Status.
Yesterday, however, Gilead Sciences asked the FDA to revoke the special status after facing ...